Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Controlling the Nature of Etched Si Nanostructures: High- versus Low-Load Metal-Assisted Catalytic Etching (MACE) of Si Powders.

Tamarov K, Swanson JD, Unger BA, Kolasinski KW, Ernst AT, Aindow M, Lehto VP, Riikonen J.

ACS Appl Mater Interfaces. 2020 Jan 29;12(4):4787-4796. doi: 10.1021/acsami.9b20514. Epub 2020 Jan 13.

PMID:
31888334
2.

Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials).

Perez IM, Jambor I, Kauko T, Verho J, Ettala O, Falagario U, Merisaari H, Kiviniemi A, Taimen P, Syvänen KT, Knaapila J, Seppänen M, Rannikko A, Riikonen J, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Pahikkala T, Boström PJ, Aronen HJ.

J Magn Reson Imaging. 2019 Nov 21. doi: 10.1002/jmri.26975. [Epub ahead of print]

PMID:
31750988
3.

Inorganic mesoporous particles for controlled α-linolenic acid delivery to stimulate GLP-1 secretion in vitro.

Kamakura R, Kovalainen M, Riikonen J, Nissinen T, Shere Raza G, Walkowiak J, Lehto VP, Herzig KH.

Eur J Pharm Biopharm. 2019 Nov;144:132-138. doi: 10.1016/j.ejpb.2019.09.009. Epub 2019 Sep 12.

PMID:
31521716
4.

Effects of Preoperative Atorvastatin Treatment On Erectile Function After Radical Prostatectomy: Results From a Subgroup of ESTO1, a Randomized, Double-Blind, Placebo-Controlled Study.

Siltari A, Riikonen J, Fode M, Murtola TJ.

J Sex Med. 2019 Oct;16(10):1597-1605. doi: 10.1016/j.jsxm.2019.07.001. Epub 2019 Aug 9.

PMID:
31405764
5.

Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.

Hackman G, Taari K, Tammela TL, Matikainen M, Kouri M, Joensuu T, Luukkaala T, Salonen A, Isotalo T, Pétas A, Hendolin N, Boström PJ, Aaltomaa S, Lehtoranta K, Hellström P, Riikonen J, Korpela M, Minn H, Kellokumpu-Lehtinen PL, Pukkala E, Hemminki A; FinnProstate Group.

Eur Urol. 2019 Nov;76(5):586-595. doi: 10.1016/j.eururo.2019.07.001. Epub 2019 Jul 30.

PMID:
31375279
6.

The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis.

Pesonen JS, Cartwright R, Vernooij RWM, Aoki Y, Agarwal A, Mangera A, Markland AD, Tsui JF, Santti H, Griebling TL, Pryalukhin AE, Riikonen J, Tähtinen RM, Vaughan CP, Johnson TM, Auvinen A, Heels-Ansdell D, Guyatt GH, Tikkinen KAO; CLUE Working Group.

J Urol. 2019 Jul 31:101097JU0000000000000463. doi: 10.1097/JU.0000000000000463. [Epub ahead of print]

PMID:
31364920
7.

The Impact of Nocturia on Falls and Fractures: A Systematic Review and Meta-Analysis.

Pesonen JS, Vernooij RWM, Cartwright R, Aoki Y, Agarwal A, Mangera A, Markland AD, Tsui JF, Santti H, Griebling TL, Pryalukhin AE, Riikonen J, Tähtinen RM, Vaughan CP, Johnson TM 2nd, Heels-Ansdell D, Guyatt GH, Tikkinen KAO.

J Urol. 2019 Jul 26:101097JU0000000000000459. doi: 10.1097/JU.0000000000000459. [Epub ahead of print]

PMID:
31347956
8.

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis.

Riikonen JM, Guyatt GH, Kilpeläinen TP, Craigie S, Agarwal A, Agoritsas T, Couban R, Dahm P, Järvinen P, Montori V, Power N, Richard PO, Rutanen J, Santti H, Tailly T, Violette PD, Zhou Q, Tikkinen KAO.

JAMA Intern Med. 2019 Jun 24. doi: 10.1001/jamainternmed.2019.0763. [Epub ahead of print]

9.

Access and concentrations of atorvastatin in the prostate in men with prostate cancer.

Knuuttila E, Riikonen J, Syvälä H, Auriola S, Murtola TJ.

Prostate. 2019 Sep;79(12):1412-1419. doi: 10.1002/pros.23863. Epub 2019 Jun 24.

PMID:
31231865
10.

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.

Jambor I, Verho J, Ettala O, Knaapila J, Taimen P, Syvänen KT, Kiviniemi A, Kähkönen E, Perez IM, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Aronen HJ, Boström PJ.

PLoS Med. 2019 Jun 3;16(6):e1002813. doi: 10.1371/journal.pmed.1002813. eCollection 2019 Jun.

12.

Active synchronization and modulation of fiber lasers with a graphene electro-optic modulator.

Li D, Xue H, Wang Y, Qi M, Kim W, Li C, Riikonen J, Ren Z, Bai J, Lipsanen H, Sun Z.

Opt Lett. 2018 Aug 1;43(15):3497-3500. doi: 10.1364/OL.43.003497.

PMID:
30067694
13.

Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial.

Murtola TJ, Syvälä H, Tolonen T, Helminen M, Riikonen J, Koskimäki J, Pakarainen T, Kaipia A, Isotalo T, Kujala P, Tammela TLJ.

Eur Urol. 2018 Dec;74(6):697-701. doi: 10.1016/j.eururo.2018.06.037. Epub 2018 Jul 18.

PMID:
30031572
14.

Extraprostatic extension (pT3a) in prostate biopsy is an under-recognized feature indicating high risk disease.

Tolonen TT, Riikonen J, Tammela TLJ, Koivusalo L, Haapasalo H, Kujala P, Kaipia A.

Ann Diagn Pathol. 2018 Aug;35:80-84. doi: 10.1016/j.anndiagpath.2018.06.001. Epub 2018 Jun 5. No abstract available.

PMID:
29886397
15.

Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.

Knaapila J, Kallio H, Hakanen AJ, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Gunell M, Boström PJ.

BJU Int. 2018 Aug;122(2):203-210. doi: 10.1111/bju.14198. Epub 2018 Apr 6.

16.

Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.

Knaapila J, Gunell M, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Hakanen AJ, Boström PJ.

Eur Urol Focus. 2019 May;5(3):443-448. doi: 10.1016/j.euf.2017.12.001. Epub 2017 Dec 20.

PMID:
29275146
17.

Mesoporous systems for poorly soluble drugs - recent trends.

Riikonen J, Xu W, Lehto VP.

Int J Pharm. 2018 Jan 30;536(1):178-186. doi: 10.1016/j.ijpharm.2017.11.054. Epub 2017 Nov 26. Review.

PMID:
29183856
18.

Biodegradation of inorganic drug delivery systems in subcutaneous conditions.

Kovalainen M, Kamakura R, Riikonen J, Finnilä M, Nissinen T, Rantanen J, Niemelä M, Perämäki P, Mäkinen M, Herzig KH, Lehto VP.

Eur J Pharm Biopharm. 2018 Jan;122:113-125. doi: 10.1016/j.ejpb.2017.10.014. Epub 2017 Oct 19.

PMID:
29056485
19.

Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues.

Högnäs G, Kivinummi K, Kallio HML, Hieta R, Ruusuvuori P, Koskenalho A, Kesseli J, Tammela TLJ, Riikonen J, Ilvesaro J, Kares S, Hirvikoski PP, Laurila M, Mirtti T, Nykter M, Kujala PM, Visakorpi T, Tolonen T, Bova GS.

Am J Surg Pathol. 2018 Jan;42(1):103-115. doi: 10.1097/PAS.0000000000000961.

PMID:
28984675
20.

Scaling of graphene field-effect transistors supported on hexagonal boron nitride: radio-frequency stability as a limiting factor.

Feijoo PC, Pasadas F, Iglesias JM, Martín MJ, Rengel R, Li C, Kim W, Riikonen J, Lipsanen H, Jiménez D.

Nanotechnology. 2017 Dec 1;28(48):485203. doi: 10.1088/1361-6528/aa9094.

PMID:
28972503
21.

Thermal suit in preventing unintentional intraoperative hypothermia during general anaesthesia: a randomized controlled trial.

Lauronen SL, Kalliomäki ML, Aho AJ, Kalliovalkama J, Riikonen JM, Mäkinen MT, Leppikangas HM, Yli-Hankala AM.

Acta Anaesthesiol Scand. 2017 Oct;61(9):1133-1141. doi: 10.1111/aas.12945. Epub 2017 Jul 25.

PMID:
28741744
22.

Contemporary and past challenges of prostate cancer diagnostics.

Kaipia A, Riikonen J.

Scand J Urol. 2017 Jun;51(3):193-201. doi: 10.1080/21681805.2017.1329902. No abstract available.

PMID:
28657393
23.

Incidence and Remission of Nocturia: A Systematic Review and Meta-analysis.

Pesonen JS, Cartwright R, Mangera A, Santti H, Griebling TL, Pryalukhin AE, Riikonen J, Tähtinen RM, Agarwal A, Tsui JF, Vaughan CP, Markland AD, Johnson TM 2nd, Fonsell-Annala R, Khoo C, Tammela TL, Aoki Y, Auvinen A, Heels-Ansdell D, Guyatt GH, Tikkinen KA.

Eur Urol. 2016 Aug;70(2):372-81. doi: 10.1016/j.eururo.2016.02.014. Epub 2016 Feb 20.

24.

Initiation of robot-assisted radical prostatectomies in Finland: Impact on centralization and quality of care.

Riikonen J, Kaipia A, Petas A, Horte A, Koskimäki J, Kähkönen E, Boström PJ, Paananen I, Kuisma J, Santti H, Matikainen M, Rannikko A.

Scand J Urol. 2016 Jun;50(3):149-54. doi: 10.3109/21681805.2016.1142471. Epub 2016 Feb 16.

PMID:
26881411
25.

Tunable Graphene-GaSe Dual Heterojunction Device.

Kim W, Li C, Chaves FA, Jiménez D, Rodriguez RD, Susoma J, Fenner MA, Lipsanen H, Riikonen J.

Adv Mater. 2016 Mar 2;28(9):1845-52. doi: 10.1002/adma.201504514. Epub 2016 Jan 4.

PMID:
26727653
26.

Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.

Korhonen E, Rönkkö S, Hillebrand S, Riikonen J, Xu W, Järvinen K, Lehto VP, Kauppinen A.

Eur J Pharm Biopharm. 2016 Mar;100:1-8. doi: 10.1016/j.ejpb.2015.11.020. Epub 2015 Dec 11.

PMID:
26686646
27.

Tuning Localized Surface Plasmon Resonance in Scanning Near-Field Optical Microscopy Probes.

Vasconcelos TL, Archanjo BS, Fragneaud B, Oliveira BS, Riikonen J, Li C, Ribeiro DS, Rabelo C, Rodrigues WN, Jorio A, Achete CA, Cançado LG.

ACS Nano. 2015 Jun 23;9(6):6297-304. doi: 10.1021/acsnano.5b01794. Epub 2015 Jun 9.

PMID:
26027751
28.

Novel delivery systems for improving the clinical use of peptides.

Kovalainen M, Mönkäre J, Riikonen J, Pesonen U, Vlasova M, Salonen J, Lehto VP, Järvinen K, Herzig KH.

Pharmacol Rev. 2015 Jul;67(3):541-61. doi: 10.1124/pr.113.008367. Review.

PMID:
26023145
29.

Investigation of second- and third-harmonic generation in few-layer gallium selenide by multiphoton microscopy.

Karvonen L, Säynätjoki A, Mehravar S, Rodriguez RD, Hartmann S, Zahn DR, Honkanen S, Norwood RA, Peyghambarian N, Kieu K, Lipsanen H, Riikonen J.

Sci Rep. 2015 May 19;5:10334. doi: 10.1038/srep10334.

30.

All-Graphene Three-Terminal-Junction Field-Effect Devices as Rectifiers and Inverters.

Kim W, Li C, Chekurov N, Arpiainen S, Akinwande D, Lipsanen H, Riikonen J.

ACS Nano. 2015 Jun 23;9(6):5666-74. doi: 10.1021/nn507199n. Epub 2015 May 15.

PMID:
25961680
31.

Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.

Riikonen J, Correia A, Kovalainen M, Näkki S, Lehtonen M, Leppänen J, Rantanen J, Xu W, Araújo F, Hirvonen J, Järvinen K, Santos HA, Lehto VP.

Biomaterials. 2015 Jun;52:44-55. doi: 10.1016/j.biomaterials.2015.02.014. Epub 2015 Feb 21.

PMID:
25818412
32.

Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study.

Tolonen TT, Isola J, Kaipia A, Riikonen J, Koivusalo L, Huovinen S, Laurila M, Porre S, Tirkkonen M, Kujala P.

BMC Clin Pathol. 2015 Mar 8;15:4. doi: 10.1186/s12907-015-0001-9. eCollection 2015.

33.

Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis.

Violette PD, Agoritsas T, Alexander P, Riikonen J, Santti H, Agarwal A, Bhatnagar N, Dahm P, Montori V, Guyatt GH, Tikkinen KA.

CA Cancer J Clin. 2015 May-Jun;65(3):239-51. doi: 10.3322/caac.21272. Epub 2015 Mar 12. Review.

34.

Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration.

Näkki S, Rytkönen J, Nissinen T, Florea C, Riikonen J, Ek P, Zhang H, Santos HA, Närvänen A, Xu W, Lehto VP.

Acta Biomater. 2015 Feb;13:207-15. doi: 10.1016/j.actbio.2014.11.019. Epub 2014 Nov 20.

PMID:
25463492
35.

Exceptionally strong and robust millimeter-scale graphene-alumina composite membranes.

Berdova M, Perros AP, Kim W, Riikonen J, Ylitalo T, Heino J, Li C, Kassamakov I, Hæggström E, Lipsanen H, Franssila S.

Nanotechnology. 2014 Sep 5;25(35):355701. doi: 10.1088/0957-4484/25/35/355701. Epub 2014 Aug 12. Erratum in: Nanotechnology. 2014 Oct 31;25(43):439501.

PMID:
25116235
36.

Nanocarriers and the delivered drug: effect interference due to intravenous administration.

Vlasova MA, Rytkönen J, Riikonen J, Tarasova OS, Mönkäre J, Kovalainen M, Närvänen A, Salonen J, Herzig KH, Lehto VP, Järvinen K.

Eur J Pharm Sci. 2014 Oct 15;63:96-102. doi: 10.1016/j.ejps.2014.06.011. Epub 2014 Jun 22.

PMID:
24964293
37.

Cell structural changes in the mesophyll of Norway spruce needles by elevated ozone and elevated temperature in open-field exposure during cold acclimation.

Kivimäenpää M, Riikonen J, Sutinen S, Holopainen T.

Tree Physiol. 2014 Apr;34(4):389-403. doi: 10.1093/treephys/tpu023. Epub 2014 Apr 8.

PMID:
24718738
38.

Injected nanoparticles: the combination of experimental systems to assess cardiovascular adverse effects.

Vlasova MA, Tarasova OS, Riikonen J, Raula J, Lobach AS, Borzykh AA, Smirin BV, Kauppinen EI, Eletskii AV, Herzig KH, Salonen J, Tavi P, Lehto VP, Järvinen K.

Eur J Pharm Biopharm. 2014 May;87(1):64-72. doi: 10.1016/j.ejpb.2014.02.001. Epub 2014 Feb 14.

PMID:
24530427
39.

Rapid large-area multiphoton microscopy for characterization of graphene.

Säynätjoki A, Karvonen L, Riikonen J, Kim W, Mehravar S, Norwood RA, Peyghambarian N, Lipsanen H, Kieu K.

ACS Nano. 2013 Oct 22;7(10):8441-6. doi: 10.1021/nn4042909. Epub 2013 Sep 16.

PMID:
24025127
40.

Highly tunable local gate controlled complementary graphene device performing as inverter and voltage controlled resistor.

Kim W, Riikonen J, Li C, Chen Y, Lipsanen H.

Nanotechnology. 2013 Oct 4;24(39):395202. doi: 10.1088/0957-4484/24/39/395202. Epub 2013 Sep 6.

PMID:
24013367
41.

Androgen ablation for low-risk prostate cancer is common among male hip fracture patients.

Kaipia A, Riikonen J, Norja H, Huhtala H, Laitinen M.

Scand J Urol. 2014 Apr;48(2):189-94. doi: 10.3109/21681805.2013.813066. Epub 2013 Jul 18.

PMID:
23865461
42.

Side-fenestrated catheter decreases leakage at the urethrovesical anastomosis after robot-assisted laparoscopic radical prostatectomy.

Riikonen J, Kaipia A, Matikainen M, Koskimäki J, Kylmälä T, Tammela TL.

Scand J Urol. 2014 Feb;48(1):21-6. doi: 10.3109/21681805.2013.777365. Epub 2013 Mar 15.

PMID:
23495792
43.

Carbohydrate concentrations and freezing stress resistance of silver birch buds grown under elevated temperature and ozone.

Riikonen J, Kontunen-Soppela S, Vapaavuori E, Tervahauta A, Tuomainen M, Oksanen E.

Tree Physiol. 2013 Mar;33(3):311-9. doi: 10.1093/treephys/tpt001. Epub 2013 Feb 20.

PMID:
23425688
44.

Development of porous silicon nanocarriers for parenteral peptide delivery.

Kovalainen M, Mönkäre J, Kaasalainen M, Riikonen J, Lehto VP, Salonen J, Herzig KH, Järvinen K.

Mol Pharm. 2013 Jan 7;10(1):353-9. doi: 10.1021/mp300494p. Epub 2012 Dec 7.

PMID:
23186283
45.

Mesoporous systems for poorly soluble drugs.

Xu W, Riikonen J, Lehto VP.

Int J Pharm. 2013 Aug 30;453(1):181-97. doi: 10.1016/j.ijpharm.2012.09.008. Epub 2012 Sep 8. Review.

PMID:
22990124
46.

Needle metabolome, freezing tolerance and gas exchange in Norway spruce seedlings exposed to elevated temperature and ozone concentration.

Riikonen J, Kontunen-Soppela S, Ossipov V, Tervahauta A, Tuomainen M, Oksanen E, Vapaavuori E, Heinonen J, Kivimäenpää M.

Tree Physiol. 2012 Sep;32(9):1102-12. doi: 10.1093/treephys/tps072. Epub 2012 Aug 29.

PMID:
22935538
47.

Surface chemistry, reactivity, and pore structure of porous silicon oxidized by various methods.

Riikonen J, Salomäki M, van Wonderen J, Kemell M, Xu W, Korhonen O, Ritala M, MacMillan F, Salonen J, Lehto VP.

Langmuir. 2012 Jul 17;28(28):10573-83. doi: 10.1021/la301642w. Epub 2012 Jul 2.

PMID:
22671967
48.

Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations.

Kaasalainen M, Mäkilä E, Riikonen J, Kovalainen M, Järvinen K, Herzig KH, Lehto VP, Salonen J.

Int J Pharm. 2012 Jul 15;431(1-2):230-6. doi: 10.1016/j.ijpharm.2012.04.059. Epub 2012 Apr 28.

PMID:
22569227
49.

Nonlinear behavior of three-terminal graphene junctions at room temperature.

Kim W, Pasanen P, Riikonen J, Lipsanen H.

Nanotechnology. 2012 Mar 23;23(11):115201. doi: 10.1088/0957-4484/23/11/115201.

PMID:
22383430
50.

Freezing tolerance and low molecular weight cryoprotectants in an invasive parasitic fly, the deer ked (Lipoptena cervi).

Nieminen P, Paakkonen T, Eerilä H, Puukka K, Riikonen J, Lehto VP, Mustonen AM.

J Exp Zool A Ecol Genet Physiol. 2012 Jan 1;317(1):1-8. doi: 10.1002/jez.722. Epub 2011 Nov 10.

PMID:
22076947

Supplemental Content

Loading ...
Support Center